Page last updated: 2024-09-03

celastrol and ng-nitroarginine methyl ester

celastrol has been researched along with ng-nitroarginine methyl ester in 1 studies

Compound Research Comparison

Studies
(celastrol)
Trials
(celastrol)
Recent Studies (post-2010)
(celastrol)
Studies
(ng-nitroarginine methyl ester)
Trials
(ng-nitroarginine methyl ester)
Recent Studies (post-2010) (ng-nitroarginine methyl ester)
885174112,6401172,342

Protein Interaction Comparison

ProteinTaxonomycelastrol (IC50)ng-nitroarginine methyl ester (IC50)
Neutrophil elastaseHomo sapiens (human)2.7
Nitric oxide synthase, endothelialHomo sapiens (human)2.1
Nitric oxide synthase, brainHomo sapiens (human)1.1167
Nitric oxide synthase, inducibleMus musculus (house mouse)2.6
Nitric oxide synthase, inducibleHomo sapiens (human)8
Collagenase 3Homo sapiens (human)2.7

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, Z; Wang, D; Xiao, S; Zhang, M1

Other Studies

1 other study(ies) available for celastrol and ng-nitroarginine methyl ester

ArticleYear
Celastrol attenuates symptoms of preeclampsia in rats by inhibiting matrix metalloproteinase-9.
    European journal of pharmacology, 2018, Jul-05, Volume: 830

    Topics: Animals; Female; Intracellular Signaling Peptides and Proteins; Kidney; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Proteins; NG-Nitroarginine Methyl Ester; Pentacyclic Triterpenes; Placenta Growth Factor; Pre-Eclampsia; Pregnancy; Rats, Sprague-Dawley; RNA, Messenger; Triterpenes; Vascular Endothelial Growth Factor Receptor-1

2018